MENU
NEWSLETTERS
MENU
SECTIONS
OTHER
CLASSIFIEDS
CONTACT US / FAQ
Recent Quotes
My Watchlist
Indicators
Markets
Stocks
ETFs
Tools
Markets:
Overview
News
Currencies
International
Treasuries

Pelthos Therapeutics Inc. Common Stock (NY:PTHS)

25.14 -1.32 (-4.99%)
Official Closing Price Updated: 8:00 PM EST, Dec 2, 2025 Add to My Watchlist
Quote
Overview Detailed Quote Charting Historical Prices
News
All News News Headlines Press Releases
Research
Quarterly Reports Insider Filings Other Filings

Price and Volume

Detailed Quote
Volume 58,002
Open 26.67
Bid (Size) 21.00 (200)
Ask (Size) 33.42 (100)
Prev. Close 26.46
Today's Range 21.61 - 26.95
52wk Range 13.88 - 54.29
Shares Outstanding N/A
Dividend Yield N/A
Chart for (: )
Intraday 1 Week 1 Month 3 Month 1 Year 3 Year 5 Year

Top News

More News
News headline image
Why Ligand Pharma, A Hidden Name Behind Two Big Drugs, Is Up 88% This Year ↗
Shares of Ligand Pharmaceuticals are absolutely flying as investors line up behind the company's unique royalty-based model. 
Via Investor's Business Daily
News headline image
Pelthos Therapeutics Inc (NYSEARCA:PTHS) Stock Rises on Strong Q3 Revenue Beat ↗
Pelthos Therapeutics (PTHS) Q3 2025 results show a huge 66% revenue beat driven by strong demand for its new product ZELSUVMI, despite a significant EPS loss. 
Via Chartmill

Performance

YTD
+52.4%
+52.4%
1 Month
-26.5%
-26.5%
3 Month
+11.9%
+11.9%
6 Month
+52.4%
+52.4%
1 Year
+52.4%
+52.4%

More News

Read More
News headline image
Earnings Scheduled For November 13, 2025 ↗
Via Benzinga
News headline image
EXCLUSIVE: Pelthos Secures Rights To Antimicrobial Drug, Raises $18 Million To Support Commercial Launch ↗
Via Benzinga
News headline image
Presenting at the Investor Summit Q3 2025 on September 16; Watch the Live Stream for Free
Via ACCESS Newswire
News headline image
12 Health Care Stocks Moving In Wednesday's Intraday Session ↗
Via Benzinga
News headline image
12 Health Care Stocks Moving In Friday's Intraday Session ↗
Via Benzinga
News headline image
Pelthos, Ligand Gain After Launch Of First Prescription-At-Home Treatment For Water Warts ↗
Via Stocktwits
Topics Government
News headline image
12 Health Care Stocks Moving In Thursday's Intraday Session ↗
Via Benzinga
News headline image
Pelthos Therapeutics Launches First At-Home Prescription Gel For Highly Contagious Skin Disease ↗
Via Benzinga
News headline image
12 Health Care Stocks Moving In Wednesday's Intraday Session ↗
Via Benzinga
News headline image
12 Health Care Stocks Moving In Tuesday's Intraday Session ↗
Via Benzinga
News headline image
Helius Medical Technologies, Sunrun And Other Big Stocks Moving Lower In Tuesday's Pre-Market Session ↗
Via Benzinga
News headline image
Why ENDRA Life Sciences Shares Are Trading Higher By Over 61%; Here Are 20 Stocks Moving Premarket ↗
Via Benzinga
News headline image
12 Health Care Stocks Moving In Monday's Intraday Session ↗
Via Benzinga

Frequently Asked Questions

Is Pelthos Therapeutics Inc. Common Stock publicly traded?
Yes, Pelthos Therapeutics Inc. Common Stock is publicly traded.
What exchange does Pelthos Therapeutics Inc. Common Stock trade on?
Pelthos Therapeutics Inc. Common Stock trades on the New York Stock Exchange
What is the ticker symbol for Pelthos Therapeutics Inc. Common Stock?
The ticker symbol for Pelthos Therapeutics Inc. Common Stock is PTHS on the New York Stock Exchange
What is the current price of Pelthos Therapeutics Inc. Common Stock?
The current price of Pelthos Therapeutics Inc. Common Stock is 25.14
When was Pelthos Therapeutics Inc. Common Stock last traded?
The last trade of Pelthos Therapeutics Inc. Common Stock was at 12/02/25 08:00 PM ET
Stock Quote API & Stock News API supplied by www.cloudquote.io
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the Privacy Policy and Terms Of Service.
© 2025 FinancialContent. All rights reserved.
TOP
Email a Story